deliver accelerated Thank on on our a start top line client-driven strong per earnings you, several $X.XX benefitted share execution in year. Simulations and to our represents unanticipated strong projects quarter. Cameron. continued objectives plan exceeded The XX% Plus from growth our to targets first that timing the growth fiscal and
a to XX% we initiatives, investments our last the increasing with to yielded we quarters most rate goal marketing results XXXX. over have and several growth our sales the as know, you historical navigated XX% encouraging six range of XX%. most fiscal of notably investments increased XX% As in These key of to of
revenue XXXX XX%. several acceleration growth improved fiscal year full delivered projects first For XX% our North was Carolina result was to that in quarter fourth the the higher revenue of the we operation due resulting our largely quarter This on further first growth expected of rate delivering the growth. in quarter. and in in We XX% than the at XXXX,
are not expectations XX% of levels maintain these full fiscal results we to While to growth XXXX, anticipating for validate year. these growth the our XX% throughout
growth software driven both our increased by revenue businesses. consulting and been has Our
XX% quarter for quarter and XX% in at first with strong grew first on of of during remain revenues margins Gross the XX%, Software margins the growth slightly quarters XXXX, the and consulting respectively. XX%. at fiscal fourth gross up XX%
revenues in mix margin richer revenues and gross which low carry to despite division our margin of or price maintain in our cost belief quarter result the personnel This higher of efficiencies. for operational achieved the was pass-through very margins. usual in revenue overall This addition through mix and we consulting improve RTP CRO management lower changes than can that despite supports
prior across opportunities and more more strong on our our Demand consulting helping additional is senior our remains capture a Through array that consulting built recruiting competencies. of software recent focus Cognigen services. us our as acquisitions scientific and DILIsym we products beyond expertise have as historical consultants, of comprehensive more well
for product highlight fatty of liver injury DILIsym, we liver drug-induced to NAFLDsym, of XX of When staff. acquired model product was fiscal revenue our consisted Systems nonalcoholic in only its DILIsym disease portfolio a Toxicology achievement the quarter this progress assessment model. XXXX, appropriate division. the Quantitative for in year-over-year and the a division Its the for is It growth made an incredible RTP XX%, quarter
syndrome. drug-induced RENAsym, fibrosis a funding radiation for and and idiopathic kidney that sourced pharmaceutical model expand RADAsym, our company From model group. to a revenue and systems to with coverage we of sources quantitative from expertise leveraged internal, have this starting and our grant-based IPFsym, therapeutic are pulmonary point, significantly model revenue a efforts model injury; from pharmacology assess acute billing additionally for Today,
expansion market the expertise. opportunity This into our for taken areas us QSP expanding therapeutic customers new new and has
revenues the mature, supplement the are from consulting the licensing opportunities software the models models more service will on horizon. As therapeutic revenues expansion and
specifically SG&A X% investments, the quarter marketing, spending percentage and sales dollars. in in SG&A the Due revenue fiscal first as to XXXX increased absolute our have the quarter was fiscal and in growth, XXXX. expenses quarter fourth of declined ongoing higher Our the versus of a first revenue up of from
as these of year revenues the seasonality XX% to expenses fluctuate of SG&A quarterly about XX% will forecast revenue. percentage based our revenue. our total expenses towards back expense full of at moving revenues. time, at revenue historical we continue We approximately to anticipate of a of SG&A upon percentage Over XX%
our to up Lancaster XX% our for revenue division, In results was quarter quarter. Turning overall first the by division.
for Software the XX% X% versus XX% consulting. to our metrics, grew were quarter last down versus from revenue from XX% revenues slightly and quarter year. from new renewals; the With Consulting licenses XX% was detailed of year. Lancaster's last for revenue regard
and based accounts based rates XX% were renewal on fees. Our XX% on
projects of industry. and the were units license XXX fiscal we have year, funded We differentiate commercial companies XX the nonprofit collaborations. within beginning Our us companies expand up of currently year-over-year. We XX groups. projects and XX% our with significant have XX the funded X added and software new of announced the These further offerings collaborations. functionality five Since
to across for advance First, software into and tautomer learning Bayer structure with integrated Predictor with the workflows. support agreement that use machine handling different ADMET discovery Bayer capabilities will entered will new we Collaboratively, we integrity improved data the develop drug a platforms. collaboration discovery
to software. and several to support the where enhance we into process followed as pharmacokinetics/toxicokinetics the evaluated collaboration program collaboration data modeling new their global internal that with rigorous a partner Simulations Second, platform entered Plus PKPlus pharmaceutical pharmaceutical competitors funded PKPlus ultimately selecting a teams. the connects This large a the company
new pharmaceutical model a in funded into an into support funded a model entered collaboration mechanistic gastrointestinal modify Fourth, new intra-articular with we GastroPlus stage to to delivery Third, in with partner collaboration GastroPlus. absorption large a the research. develop oral clinical we a company entered to disease biotech
reduce history GastroPlus. new input entered we collaborations These finally, with virtual to and a And overall the products. revenue module funding trial our the large first collaboration and costs continue partner collaboration year-to-date agreement Despite R&D confidence in pharmaceutical in targets. industry-leading with service enhance to leveraging a software client quarter, of division provide for flat our in simulator develop year closures the associated the revenues our full the bioequivalence achieving funded maintaining
one XX time from with the last up at four revenue growth quarter the full ended Buffalo, XX% in In achieved prior XX our XX quarter for division, we the quarter. Lancaster We up from and employees year.
consulting has fiscal have in high fiscal with in As XXXX to quarter. that marketplace. offer XXXX type a remains of X% the Demand reminder, we increased growth and at the XX% this in fiscal we division XXXX started from solid services PK/PD for Buffalo a
a In to support five staff, our the adding consulting quarter with new growth of of one for successful a the expectations employees attrition. recruiting four year, fiscal we net had
we the XX are Buffalo meet quarter We and client prior associated positioned our at While up quarter onboarding growth our demand from recruiting XX for to this expectations the and costs believe time employees impacted XX the division, in ended from up profitability full we year. division’s year. last with well and quarter, the fiscal
the Our delivered revenue RTP growth for XX% quarter. division that
DILIsym meet division for and projects request The quarter. from mentioned development team accelerated regulatory above at special two earlier, beyond going needs. deserves the benefited As this and were significant who I credit to this at customer’s
other fourth I to various of at and new As addition this full division client in areas mentioned in QSP for capacity in is support large call, projects. quarter disease our in collaborations operating several platforms consulting
effort request in a comparison required plus growth our modest to consolidated forward factor This drove year to in the additional was and quarter projects XX% effort. XX% the overall. relatively a The pull and tremendous ago revenue quarter key growth two hours
at the well we we significant growth cannot expect reinforcements growth. end, and two And who continue team done seek next additional starting month do have in these RTP. that Job Carolina. While are continued expect to to for the continued additional we recruited group North to levels,
turn the over Let call to John? detailed the to me John financial now results. review